Cargando…
Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
PURPOSE: The aim of the study was to analyze the outcomes of photodynamic therapy (PDT) with intravitreal anti-vascular endothelial growth factor (anti-VEGF) for patients with polypoidal choroidal vasculopathy (PCV) having visual acuity (VA) better than 20/60 in a real-world scenario in India. METHO...
Autores principales: | Jain, Prashant, Anantharaman, Giridhar, Gopalakrishnan, Mahesh, Goyal, Anubhav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080467/ https://www.ncbi.nlm.nih.gov/pubmed/30038155 http://dx.doi.org/10.4103/ijo.IJO_1222_17 |
Ejemplares similares
-
Spontaneous formation and closure of full thickness macular hole after treatment with anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy
por: Sethia, Abhishek, et al.
Publicado: (2019) -
Management of recalcitrant polypoidal choroidal vasculopathy by feeder vessel laser photocoagulation
por: Sheth, Jay, et al.
Publicado: (2018) -
Commentary: Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
por: Kumar, Atul, et al.
Publicado: (2018) -
Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients
por: Anantharaman, Giridhar, et al.
Publicado: (2010) -
Wide-field montage image of spectral domain optical coherence tomography in polypoidal choroidal vasculopathy
por: Ranjith, P C, et al.
Publicado: (2019)